Search for company
Explore more than 1.3 million company profiles from emerging markets

Wyeth Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Select Items to chart them. 2015 Q2
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 5,887,300
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: World's Vest Base, EMIS Company Database.
Company Description

Wyeth Ltd. is a Biopharmaceutical Company. The company, a subsidiary of Pfizer Inc., engages in vaccines and women's health. Wyeth offers oral contraceptives, folic acid and depilatory cream. The company introduced vaccines against HIB and invasive pneumococcal disease in India. Incorporated in 1947, Wyeth is based in Mumbai.

Main Products

Feed Supplements, Tooth Brushes, Veterinary Powders, Veterinary Robenidine ( Cycostat ), Veterinary Avoparcin ( Avotan ), Maduramycin, Corticosteriods & Hormones, Demethyl Chlortetracycline, Drops (Opthalmic, Nasal & Optic), Drops, Formulation (Injectibles), Chlortetracycline, Formulation…

Contact Information

Legal Address
Level 6, Platina,Plot No C 59, G Block,Bandra Kurla Complex
Mumbai; Maharashtra; Map
Postal Code: 400098
Tel: +91-02226574000
Fax: +91-02226574100

Full name: Wyeth Limited

Previous name(s): WYETH LEDERLE LIMITED. (1998)

Status: Delisted
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: L85190MH1947PLC005963
ISIN Code: INE300901019
Incorporation Date: 1947

Basic Information
Total Employees:
Outstanding Shares:
: ()
: ()
Registered Capital:
Financial Auditors:
2013: Imports INR 2,465,382.00 Thousands
Import connections ('000)
2013: Exports INR 362,033.00 Thousands
Export connections ('000)
Key Executives
Director & Member
Ownership Details
Wyeth Llc
Affiliates and related companies
Wyeth Lederle Exports Ltd.
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - India

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.